Page last updated: 2024-08-23

diltiazem and Carcinoma 256, Walker

diltiazem has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chopra, H; Fligiel, SE; Hatfield, JS; Honn, KV; Onoda, JM; Rong, X; Taylor, JD; Timar, J	1

Other Studies

1 other study(ies) available for diltiazem and Carcinoma 256, Walker

Article	Year
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:6 Topics: Animals; Calcium Channel Blockers; Carcinoma 256, Walker; Cytoskeleton; Diltiazem; Epitopes; Female; Integrins; Microscopy, Electron; Microtubules; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tumor Cells, Cultured; Verapamil	1992

Article

Year

Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.

Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:6

Topics: Animals; Calcium Channel Blockers; Carcinoma 256, Walker; Cytoskeleton; Diltiazem; Epitopes; Female; Integrins; Microscopy, Electron; Microtubules; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tumor Cells, Cultured; Verapamil

1992